Needling standard work-up.

Recognizing multiparametric prostate MRI as a non-invasive and effective, if not cheap, screening tool prior to biopsy, this cost-effective modeling points to this strategy providing quite the quality of life bang for the buck if used with a calculated 10-year absolute risk threshold of ≥7.5%. | Callender, JAMA Netw Open 2021